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Background & Aims: We have shown that taurocholate
(TC) and taurolithocholate (TLC) interact in vitro with
normal cholangiocytes, increasing DNA synthesis, se-
cretin receptor (SR) gene expression, and adenosine
38,58-cyclic monophosphate (cAMP) synthesis. To fur-
ther extend these in vitro studies, we tested the
hypothesis that bile acids (BAs) directly stimulate
cholangiocyte proliferation and secretion in vivo.
Methods: After feeding with TC or TLC (1% for 1–4
weeks), we assessed the following in vivo: (1) ductal
proliferation by both morphometry and immunohisto-
chemistry for proliferating cell nuclear antigen (PCNA)
and measurement of [3H]thymidine incorporation; and
(2) the effect of secretin on bile secretion and bicarbon-
ate secretion in vivo. Genetic expression of H3-histone
and SR and intracellular cAMP levels were measured in
isolated cholangiocytes. Results: After BA feeding,
there was an increased number of PCNA-positive chol-
angiocytes and an increased number of ducts com-
pared with control rats. [3H]Thymidine incorporation,
absent in control cholangiocytes, was increased in
cholangiocytes from BA-fed rats. In BA-fed rats, there
was increased SR gene expression (approximately
2.5-fold) and secretin-induced cAMP levels (approxi-
mately 3.0-fold) in cholangiocytes, which was associ-
ated with de novo secretin-stimulated bile flow and
bicarbonate secretion. Conclusions: These data indi-
cate that elevated BA levels stimulate ductal secretion
and cholangiocyte proliferation.
Cholangiocytes that line the intrahepatic biliary treesecrete water and electrolytes in response to hor-
mones.1–3 Secretin stimulates ductal bile secretion by
interacting with secretin receptor (SR) present only on
cholangiocytes,2 resulting in increases in intracellular
adenosine 38,58-cyclic monophosphate (cAMP) synthesis.3,4
Cholangiocytes are normally in a quiescent state.3,4 In
experimental models of ductal hyperplasia, such as bile
duct ligation (BDL) or 70% hepatectomy, cholangiocytes
proliferate markedly, leading to enlargement of intrahe-
patic ductal mass.1,3 Cholangiocyte proliferation is closely
coupled with increased DNA synthesis, SR gene expres-
sion, secretin-induced cAMP synthesis, and secretin-
stimulated bicarbonate-rich choleresis.1–3
Bile acids (BAs) interact with cholangiocytes and alter
cholangiocyte secretion and growth.4–8 To explain a
bicarbonate-rich hypercholeresis after administration of
certain BA, a ‘‘cholehepatic shunt pathway’’ has been
proposed, suggesting that protonated BAs in the lumen
of bile ducts are reabsorbed by cholangiocytes.7 Toxic
hydrophobic BAs accumulate in both the blood circula-
tion and liver in patients with chronic liver disease.
Previous studies have shown toxicity of hydrophobic BAs
to hepatocytes9,10 and bile ducts.11 We have shown that,
in vitro, both taurocholate (TC) and taurolithocholate
(TLC) increase DNA synthesis, SR gene expression, and
secretin-stimulated cAMP levels.4 Furthermore, we and
others5,12 have shown functional and genetic expression of
the sodium-dependent apical bile acid transporter (ABAT)
in the cholangiocyte apical membranes. This Na1-
dependent ABAT probably plays an important role in the
BA effects on cholangiocyte proliferation and secretion
because BAs alter cholangiocyte function in vitro only in
the presence of sodium, and ABAT in cholangiocytes has
a Michaelis constant (Km) for TC similar to the BA
concentration at which the maximum effects of BA on
cholangiocyte secretory and proliferative functions are
observed in vitro.4,12 Thus, we propose that uptake of
BAs from bile by ABAT initiates signals that modulate
cholangiocyte proliferation and secretion.4,12
In this study, we wanted to determine whether in-
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creased biliary BA concentrations could directly stimu-
late in vivo cholangiocyte proliferation and ductal secre-
tion in the absence of cholestasis or hepatic injury. We
experimentally increased biliary BA concentration by
feeding rats TC (a physiologically relevant BA) or TLC
(which has been shown to induce ductal hyperplasia in
rodents8) for 1–4 weeks. There is enrichment13 and a
2–3-fold increase in the BA pool14 with the adminis-
trated BA in BA-fed rats. In rats fed TC or TLC, we found
that BA concentrations were increased in bile but not in
serum and that there was no biochemical or histological
evidence of hepatic damage or cholestasis, yet there was
cholangiocyte proliferation and increased ductal secretion.
Materials and Methods
Animal Model and Materials
Male Fischer 344 rats (125–150 g) from Charles River
(Wilmington, MA) were used in the present studies. The
animals were kept in a temperature-controlled environment
(20–22°C) with alternating 12-hour light-dark cycles. The
studies were conducted in rats fed 1% TC or 1% TLC,
representing approximate doses of 275 and 260 µmol/day,
respectively, for 1–4 weeks. Rat chow containing 1% TC, 1%
TLC, or AIN 76 (control diet) was prepared by Dyets Inc.
(Bethlehem, PA). Rats were fasted overnight before experi-
ments. Before each protocol, rats were anesthetized with sodium
pentobarbital (50 mg/kg intraperitoneally). Reagents were pur-
chased from Sigma Chemical Co. (St. Louis, MO) unless otherwise
indicated. N(g-L-glutamyl)-4-methoxy-2-naphthylamide, the
substrate for g-glutamyltranspeptidase (g-GT), was purchased
from Polysciences (Warrington, PA). Both TC and TLC were
purchased from Calbiochem-Novabiochem Corp. (La Jolla, CA).
Determination of Liver Inflammation
and Hepatic Damage
After TC or TLC feeding, the degree of liver inflamma-
tion was assessed by the grade system described by Davis and
Madri.15 H&E-stained liver sections were graded for the degree
of inflammation in a coded fashion as follows: 0, normal; 11,
triad-based; 12, triad-based with focal parenchymal inflamma-
tion without necrosis; 14, triad-based with lobular inflamma-
tion with unicellular necrosis; and 15, confluent necrosis. To
determine whether BA feeding induces liver damage, the
serum levels of selected enzymes associated with hepatic
damage (serum glutamic pyruvic transaminase [SGPT], serum
glutamic oxalacetic transaminase [SGOT], g-glutamyl transfer-
ase (GGT), alkaline phosphatase, and both total and direct
bilirubin) were measured by use of commercially available kits
(Sigma).
Purification of Cholangiocytes From
Normal and BA-Fed Rats
Pure (by g-GT histochemistry; results not shown)
preparations of cholangiocytes from control and BA-fed rats
were obtained as previously described.2,3,16,17 Briefly, after
standard collagenase perfusion,17 a cholangiocyte-enriched frac-
tion (40%–55% pure by g-GT) was obtained from intact
portal tracts, as described by Ishii et al.,17 and subsequently
purified by immunoaffinity separation.3,17
Assessment of Intrahepatic Ductal Mass
in Normal and BA-Fed Rats
Intrahepatic duct mass was calculated by point count
analysis3,18 by determination of the fraction of total matrix of
points overlapping bile ducts, stained for g-GT,19 in coded
frozen liver sections (6 µm) from normal and BA-fed rats (n 5
12). In each liver section, the entire area was examined by
multiple photographs taken in a mosaic fashion. From the total
number of points over hepatic tissue and the number of points
over g-GT–positive ducts, we calculated the volume percent of
liver occupied by ducts.3,18
Indirect immunohistochemistry was performed to detect
proliferating cellular nuclear antigen (PCNA) in proliferating
bile ducts. Briefly, formalin-fixed liver sections were deparaf-
fined, followed by microwave treatment (5 minutes in water at
500 W). After adequate blocking of endogenous peroxidase
activity by methanol-peroxidase solution, nonspecific binding
was blocked by incubation with normal goat serum for 30
minutes at room temperature. Sections were incubated with
anti-PCNA antibody (clone PC-10; Oncogene Research Prod-
ucts, Cambridge, MA) at 4°C overnight. After several washes
with cold phosphate-buffered saline, biotin-labeled secondary
antibody at a dilution of 1:100 (Dako, Kyoto, Japan) was added
for 1 hour at room temperature. For detection of this reaction, a
peroxidase-labeled avidin-biotin complex with diaminobenzi-
dine (Dojin Chemical Co, Kumamoto, Japan) was used as a
substrate. Sections were counterstained with hematoxylin and
examined with a microscope (Olympus Optical Co., BX 40,
Japan); 300–400 cholangiocytes were analyzed for each inter-
val.
In Vivo Measurement of [3H]Thymidine
Incorporation in Cholangiocytes
We measured DNA synthesis of pure cholangiocytes
from control and BA-fed rats by measuring of [3H]thymidine
incorporation as described previously.3
Measurement of H3-Histone and SR
Gene Expression
Steady-state levels of H3-histone and SR messenger
RNAs (mRNAs) were measured by the lysate ribonuclease
(RNase) protection assay (Direct Protect kit; Ambion Inc.,
Austin, TX).3,4 The phenotypic characteristics of cholangio-
cytes from normal and BA-fed rats were assessed by hybridiza-
tion with cytokeratin 19 (CK-19), a specific marker of
cholangiocytes.3 The comparability of the cell lysate used was
determined by hybridization with glyceraldehyde-3-phosphate
dehydrogenase (GAPDH).2,4,16 Antisense mRNA probes were
transcribed from selected complementary DNA (cDNA) linear-
ized templates using the Maxiscript kit (Ambion Inc.).
180 ALPINI ET AL. GASTROENTEROLOGY Vol. 116, No. 1
Measurement of Intracellular cAMP Levels
After purification, cholangiocytes (1 3 105) were
incubated for 5 minutes at 22°C3 with 1027 mol/L secretin
(Peninsula Laboratories, Belmont, CA) or 1% bovine serum
albumin (control), and intracellular cAMP levels were mea-
sured by radioimmunoassay (Amersham, Arlington Heights,
IL) as described previously.3,4,16
Measurement of Spontaneous and
Secretin-Stimulated Bile Flow
In control and BA-fed rats, bile secretion and bicarbon-
ate secretion were measured as described.1,3,16 Briefly, one
jugular vein was incannulated with a PE 50 cannula (Clay-
Adams, New York, NY) to infuse Krebs–Henseleit bicarbonate
solution (KRH) or secretin dissolved in KRH. When steady-
state bile flow was achieved, secretin (1027 mol/L) was infused
for 30 minutes followed by a final infusion of KRH for 60
minutes. Bile was collected at 10-minute intervals, placed in
preweighed tubes, and immediately stored at 270°C. Bicarbon-
ate concentration (measured as total CO2) in bile was deter-
mined with a Natelson microgasometer apparatus (Scientific
Industries, Bohemia, NY). Fasting animal blood was collected
for determination of serum BA levels. The levels of total BA in
bile or serum were determined by the 3a-hydroxysteroid
dehydrogenase procedure20 using a commercially available kit
according to the instructions supplied by the vendor (Wako
Chemicals USA, Inc., Richmond, VA). Aliquots of bile ex-
tracted with 4 volumes of isopropanol were analyzed for
individual bile salt by reverse-phase high-performance liquid
chromatography using an acidic isocratic phosphate buffer as
previously described.21
Statistical Analysis
All data are expressed as means6 SE. Differences
between groups were analyzed by the Student unpaired t test
when 2 groups were analyzed or analysis of variance (ANOVA)
when more than 2 groups were analyzed.
Results
Serum and Bile Concentration
and Composition
There was a significant increase in total BA
concentration in bile obtained from TC- or TLC-fed rats
compared with control rats (Table 1). In contrast, no
increase in serum total BA in TC-fed rats and a modest
decrease in serum total BA in TLC-fed rats were observed
(Table 1). The finding of no increase in serum total BA
levels in BA-fed rats indicates that BA feeding with the
amount chosen in our experiments does not induce
cholestasis. BA composition of bile samples obtained
from control and TC- and TLC-fed rats (Table 2) shows
enrichment of bile with the fed BA.
Determination of Liver Inflammation and
Hepatic Damage
Portal inflammation was not seen in rat liver
sections after feeding with TC, TLC, or control diet.
Hepatic inflammation scores were similar in rats fed TC,
TLC, and control diet (results not shown). Serum levels of
SGPT, SGOT, GGT, alkaline phosphatase, and both total
and direct bilirubin were not significantly different
in BA-fed rats and rats fed a control diet (results not
Table 1. BA Concentration in Bile and Serum and Basal and Secretin-Induced Bile Flow and Biliary Composition in Control,
TC-Fed, and TLC-Fed Rats
Treatment
BA levels
(mEq/L)
Bile secretion
(mL · min21 · kg21)
Bicarbonate concentration
(mEq/L)
Bicarbonate secretion
(mEq · min21 · kg21)
Bile Serum Basal Secretin Basal Secretin Basal Secretin
Control 2.82 6 0.22 0.056 6 0.001 91.85 6 14.48 86.99 6 14.5 24.46 6 1.98 27.00 6 0.57 2.19 6 0.21 2.36 6 0.35
TC, 1 wk 11.23 6 2.54a 0.049 6 0.003 126.64 6 16.21 136.90 6 17.6 22.82 6 0.68 32.07 6 1.10d 2.71 6 0.42 4.54 6 0.54e
TC, 2 wk 8.76 6 0.83a 0.045 6 0.004 91.22 6 2.25 105.49 6 3.2c 28.32 6 1.14 30.72 6 0.75 2.58 6 0.09 3.23 6 0.08e
TC, 3 wk 8.73 6 0.95a 0.064 6 0.001 82.56 6 7.09 102.68 6 6.6c 30.15 6 0.27 33.67 6 0.33d 2.48 6 0.30 3.45 6 0.35e
TC, 4 wk 6.38 6 0.26a 0.032 6 0.002 79.97 6 7.64 96.84 6 6.8c 26.85 6 1.35 31.96 6 0.75d 2.15 6 0.24 2.86 6 0.21e
TLC, 1 wk 3.15 6 1.02b 0.010 6 0.002 85.35 6 4.44 102.51 6 3.3c 29.88 6 0.22 34.68 6 2.19d 2.54 6 0.12 3.57 6 0.30e
TLC, 2 wk 4.09 6 0.57a 0.011 6 0.001 65.09 6 8.00 75.14 6 7.9 29.87 6 0.69 32.37 6 2.19d 1.95 6 0.24 2.42 6 0.25b
TLC, 3 wk 3.43 6 0.19a 0.006 6 0.001 88.09 6 3.50 100.93 6 7.0c 22.67 6 2.31 26.35 6 0.70d 1.91 6 0.21 2.66 6 0.16e
TLC, 4 wk 3.79 6 0.11a 0.009 6 0.003 58.83 6 3.83 72.95 6 4.1c 30.80 6 1.32 34.83 6 1.56d 1.81 6 0.14 2.52 6 0.11e
NOTE. Data are means 6 SE of at least 10 values from control rats and rats fed 1% TC or 1% TLC for 1–4 weeks. BA levels in bile and serum from
control and BA-fed rats were measured as described in Materials and Methods using commercially available kits.
aP , 0.05 by the unpaired Student t test compared with the corresponding values of normal control rats. Values are mean 6 SE for 6–10 rats and
obtained at steady-state conditions of bile flow. After an equilibration period of 60 minutes with KRH solution, secretin was infused via a jugular
vein for 30 minutes at 1027 mol/L.
bNot significant.
cP , 0.05 vs. basal bile secretion.
dP , 0.05 vs. basal bicarbonate concentration of normal control rats.
eP , 0.05 vs. basal bicarbonate secretion.
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shown). The data suggest that BA feeding results in
neither hepatocellular necrosis nor cholestasis.
Proliferative Activity of Cholangiocytes
From Control and BA-Fed Rats
Only 2–3 bile ducts (stained for g-GT or PCNA)
were present in portal areas of liver sections from control
rats (Figure 1). A marked increase in the number of bile
ducts (stained for g-GT or PCNA) per portal area was
observed after TC or TLC feeding (Figure 1; at 1 week of
feeding, representative experiments). In situ quantitative
morphometric analysis showed a marked increase in the
number of bile ducts (stained for g-GT) after BA feeding
for 1–4 weeks compared with control rats (Figure 2).
Similarly, the percentage of PCNA-positive cholangio-
cytes was significantly increased with 1–4 weeks of BA
feeding compared with controls (Figure 2). DNA synthe-
sis of control cholangiocytes, measured by [3H]thymidine
incorporation, was very low (Figure 3). In contrast,
[3H]thymidine incorporation in purified cholangiocytes
was markedly increased after TC or TLC feeding from
1–4 weeks (Figure 3). DNA synthesis, measured as H3-
histone gene expression, was very low in control cholan-
giocytes (Figure 4).3 In contrast, after TC or TLC feeding
for 1–4 weeks, there was a marked increase (15–20-fold)
in H3-histone gene expression compared with control
cholangiocytes (Figure 4). Expression of both GAPDH
and CK-19 mRNAs was similar among cholangiocytes
from control and BA-fed rats (Figures 4 and 5).
Secretory Activity of Cholangiocytes From
Control and BA-Fed Rats
Parallel to increased ductal proliferation observed
in BA-fed rats, SR gene expression increased (2–3-fold) in
Figure 1. Staining for (A–C) PCNA and (D–F ) g-GT in sections from (A and D) control, (B and E ) TC-fed, or (C and F ) TLC-fed rats. After TC and TLC
feeding (at 1 week, a representative experiment), there was a marked increase in the number of PCNA-positive cholangiocytes and bile ducts
(original magnifications 1253 and 1603; g-GT staining in control rats). Arrows indicate cholangiocytes and bile ducts positive for PCNA or g-GT,
respectively.
Table 2. BA Composition in Bile Obtained From Control, TC-Fed, and TLC-Fed Rats
Treatment
Muricholic acid
(mmol/L)
Taurocholic acid
(mmol/L)
Taurochenocholic acid
(mmol/L)
Taurodeoxycholic acid
(mmol/L)
Taurolithocholic acid
(mmol/L)
Control 2.16 6 0.15 0.58 6 0.06 0.05 6 0.01 0.02 6 0.005 Not detectable
TC, 1 wk 3.40 6 0.87 6.03 6 1.72a 0.22 6 0.07 0.48 6 0.18a Not detectable
TC, 2 wk 2.96 6 0.45 5.65 6 0.24a 0.15 6 0.06 0.14 6 0.03a Not detectable
TC, 3 wk 2.44 6 0.22 5.87 6 0.71a 0.10 6 0.02 0.31 6 0.08a Not detectable
TC, 4 wk 1.66 6 0.21 4.38 6 0.26a 0.06 6 0.006 0.24 6 0.03a Not detectable
TLC, 1 wk 1.65 6 0.11 0.45 6 0.09 0.09 6 0.009 0.03 6 0.006 0.46 6 0.14a
TLC, 2 wk 2.32 6 0.50 0.66 6 0.11 0.29 6 0.07a 0.028 6 0.001 0.34 6 0.03a
TLC, 3 wk 1.67 6 0.24 0.86 6 0.10 0.16 6 0.02a Not detectable 0.35 6 0.04a
TLC, 4 wk 2.15 6 0.05 1.11 6 0.08 0.22 6 0.03a Not detectable 0.30 6 0.05a
NOTE. Values are means 6 SE of at least 6 rats and were obtained in the first 10 minutes of bile collection. BA composition in bile samples from
control, TC-fed, and TLC-fed rats was measured by standard high-performance liquid chromatography.
aP , 0.05 vs. corresponding value of BA-fed control rats.
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cholangiocytes from both TC- and TLC-fed rats com-
pared with control cholangiocytes (Figure 5). Basal
intracellular cAMP levels in cholangiocytes from TC- or
TLC-fed rats were similar to those in control cholangio-
cytes (Figure 6). Although secretin significantly in-
creased cAMP levels in cholangiocytes from rats fed a
control diet, the increases in cAMP levels were signifi-
cantly greater (P , 0.05) in cholangiocytes from rats fed
TC or TLC for 1–4 weeks (see Figure 6). The effects of BA
feeding on bile and both bicarbonate concentration and
secretion are shown in Table 1. TC or TLC feeding
resulted in increases in secretin-induced bile flow and
both bicarbonate concentration and secretion (Table 1).
The findings of increased SR gene expression, secretin-
stimulated cAMP synthesis in cholangiocytes, and secre-
tin-stimulated bile flow and bicarbonate secretion are
consistent with increased duct secretion in BA-fed rats.
Discussion
Our studies show that after feeding, BAs in vivo
interact with cholangiocytes and stimulate proliferative
and secretory processes of these cells. There was an
increase in the number of bile ducts in BA-fed rats
compared with control rats with the absence of biochemi-
cal or histological evidence of hepatic injury or cholesta-
sis. Parallel with changes in ductal mass, DNA synthesis,
SR gene expression, and secretin-stimulated cAMP levels
Figure 2. In situ quantitative morphometric analysis of the number of PCNA-positive cholangiocytes and number of bile ducts in liver sections
stained for g-GT (see Materials and Methods). For each interval, 300–400 cholangiocytes were analyzed. *P , 0.05 vs. control rats.
Figure 3. Ninety minutes after an intraperitoneal administration of 1
µCi/g body wt of [methyl-3H]thymidine, the radioactivity incorporated
into DNA was measured in cholangiocytes from control, TC-fed, and
TLC-fed rats. *P , 0.05 compared with control cholangiocytes. Data
are means 6 SE of 3 experiments.
Figure 4. Expression of selected messages was determined by direct
RNase protection assay using cell lysate samples, each containing
4.50 3 105 pure cholangiocytes from control and BA-fed rats.
Autoradiograms (n 5 3) were quantified by densitometry.
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all markedly increased in cholangiocytes from BA-fed
rats compared with control rats. In vivo, secretin mark-
edly increased bile flow and both biliary bicarbonate
concentration and secretion in BA-fed rats compared
with absence of secretin-induced ductal secretion in
controls. The data suggest that BAs modulate ductal bile
secretion in the normal state and may induce ductal
proliferation in the disease state (with BA accumulation).
When circulatory levels of BA are elevated with
cholestasis, BA may be toxic to hepatocytes because of
changes in hepatocyte Ca21 and Mg21, as shown by
Spivey et al.,9 and adenosine triphosphate depletion.10 In
the BA-fed rat model, cholangiocytes respond with
increased proliferation and secretion in the absence of
biochemical or histological evidence of hepatocyte injury
or cholestasis. Similar effects with both TC and the more
potentially hepatotoxic TLC were noted in these studies,
showing that BAs per se, not their toxicity potential,
cause changes in the BA-fed model. Although short-term
TLC administration produces severe cholestasis in rats22
and cholestasis and fibrosis in rabbits,23 our current study
and a previous study22 showed that long-term TLC
administration in rats does not produce cholestasis or
hepatic injury.24 Progressive increases in proliferation and
secretion were not observed after 1 week of BA feeding.
Counterbalancing factors may come into play after 1
week that down-regulate cholangiocyte proliferation and
ductal secretion. The present findings contrast with other
models of ductal hyperplasia induced by injury, toxins, or
cholestasis (e.g., 1-naphthylisothiocyanate feeding and
BDL) in which cholangiocytes progressively proliferate
up to 1 month.1 Similar to our findings in cholangio-
cytes, BAs have been shown to stimulate hepatocyte
proliferation associated with partial hepatectomy25 and
pancreatic acinar secretion.26
These data provide new insights into the physiological
role of BA in the intrahepatic biliary ductal system. We
have shown that BAs are absorbed by the apical mem-
brane of cholangiocytes because of the presence of the
Na1-dependent BA transporter, ABAT,12 and that Na1-
dependent BA transport in cholangiocytes is regulated by
secretin.27 Na1-dependent BA uptake across the apical
membrane of cholangiocytes appears to be required for
BAs to alter cholangiocyte function because in vitro, BAs
increase cholangiocyte proliferation and ductal secretion
Figure 5. Genetic expression of SR in cholangiocytes from control and
BA-fed rats. Molecular analysis was performed by RNase protection
assays using cell lysate samples each containing 4.50 3105 cholan-
giocytes. Data are mean 6 SE of 3 experiments.
Figure 6. Intracellular cAMP levels in cholangiocytes from control and rats fed (A) 1% TC and (B) 1% TLC for 1–4 weeks. *P , 0.05 vs. basal value.
#P , 0.05, secretin-induced cAMP levels of cholangiocytes from BA-fed rats differing from secretin-induced cAMP levels of cholangiocytes from
control rats. Data are mean 6 SE of 6 experiments.
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only in the presence of Na1.4 This study shows that
exposure of increased BA levels to the apical (bile) but not
basolateral (blood) cholangiocyte membrane stimulates
cholangiocyte proliferation and ductal secretion. The
studies do not exclude the possibility that high circulat-
ing BA levels, which occur in cholestasis, may also
directly alter cholangiocyte function. Our previous experi-
ments show that only certain-sized bile ducts (large but
not small) respond to BA and that the distribution of
ABAT resides in the same-sized ducts.4 Similar correla-
tion exists between the amount of solute load handled by
different kidney tubule segments and the degree of
tubule hyperplasia and hypertrophy.28 Because it has been
suggested that kidney tubule hyperplasia/hypertrophy
compensates for the increased solute load,28 we speculate
that bile duct hyperplasia in BA-fed rats is compensating
for increased biliary BAs. Additional studies showing
increased transport activity of ABAT in cholangiocytes
from BA-fed rats would support this concept. In addition
to ABAT, another BA transport system has been demon-
strated in cholangiocytes,6 but the properties of this
transporter make it an unlikely candidate target for BA
effects on cholangiocyte function because it has a basolat-
eral location and no dependence on Na1.
The intracellular signaling mechanisms for BA-
stimulated cholangiocyte secretion and growth have not
been established. Because BAs directly stimulate cholan-
giocyte cAMP synthesis,4 and elevated cholangiocyte
cAMP levels are present in cholangiocyte hyperplasia,16
cAMP is one likely signal. Consistent with this idea,
preliminary data from our laboratory suggest that reduc-
tion of high biliary BA concentrations in BDL rats
reduces cholangiocyte cAMP levels and reverses increased
cholangiocyte proliferation.29 Other preliminary studies
from our laboratory show that ursodeoxycholic acid
(UDCA), which does not alter cAMP levels, fails to
increase cholangiocyte proliferation or secretion in nor-
mal cholangiocytes.4 In contrast, we have observed that in
UDCA-treated cholangiocytes from BDL rats and in
UDCA-fed BDL rats,30 the elevated cholangiocyte cAMP
levels and increased cholangiocyte proliferation and secre-
tion associated with BDL are ablated. Thus both up- and
down-regulation of cholangiocyte proliferation and secre-
tion by BAs are linked to cholangiocyte cAMP synthesis.
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